Nrg Oncology
Clinical trials sponsored by Nrg Oncology, explained in plain language.
-
Mesothelioma radiation trial ends early: limited results
Disease control TerminatedThis study tested whether adding targeted radiation therapy to surgery and chemotherapy could help people with early-stage malignant pleural mesothelioma live longer. The trial was stopped early and only enrolled 16 people, so it is not clear if the radiation helped. The approach…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 26, 2026 03:10 UTC
-
Bladder cancer radiation trial halted early
Disease control TerminatedThis study looked at whether giving radiation therapy after bladder removal surgery could help prevent cancer from coming back in the pelvis. It included 14 people with advanced bladder cancer. The trial was stopped early, so we don't have clear answers on whether the radiation h…
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
Liver cancer radiation trial ends early after just one patient
Disease control TerminatedThis study aimed to see if adding focused radiation to standard chemotherapy could help people with a type of liver cancer (intrahepatic cholangiocarcinoma) that cannot be surgically removed. The trial planned to compare survival and side effects between chemo alone and chemo plu…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 26, 2026 02:48 UTC
-
Brain cancer study halted: new radiation methods tested for recurrent tumors
Disease control TerminatedThis study looked at two ways to treat cancer that has spread to the brain and returned after initial radiation. One method used focused radiation only on the new tumors, while the other used whole-brain radiation while trying to protect memory areas and adding a medication to re…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Step tracking in lung cancer care: a missed opportunity?
Knowledge-focused TerminatedThis study tested whether monitoring daily step counts in people with locally advanced non-small cell lung cancer during chemoradiotherapy could help doctors provide better supportive care and reduce hospital stays or treatment delays. Only 3 participants were enrolled before the…
Phase: NA • Sponsor: NRG Oncology • Aim: Knowledge-focused
Last updated May 26, 2026 03:04 UTC